The markets opened mixed with the Dow slipping 7 points to 16,485 while Nasdaq rose 7 points to 4360 after last week's massive sell-off.
On the upside
Pike (NYSE: PIKE) agreed to be taken private by Court Square Capital Partners for a premium of $12 per share in cash.
Speculation that Tekmira Pharmaceuticals (Nasdaq: TKMR) may initiate a clinical trial with human patients who are infected with Ebola lifted shares of the biopharmaceutical.
Shares of Mobileye (NYSE: MBLY) continued climbing.
On the downside
Insmed (Nasdaq: INSM) will conduct two Phase 3 studies of its inhaled antibiotic Arikayce which disappointed investors who had hoped for regulatory approval without additional clinical trials.
ITT Educational Services (NYSE: ESI) entered into a fourth amendment to its credit agreement.
Alere (NYSE: ALR) reported a wider than expected loss for the second quarter as revenue dropped.
In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 2 on the NYSE and by nearly 7 to 3 on Nasdaq. The broader S&P 500 lost 5 points to 1925. Bitcoin added $2 to $586.
